Atriance
Active substance: nelarabine
nelarabine
Centralised EU authorisationActive
Marketing holder: Sandoz Pharmaceuticals d.d.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 3 |
|
| US 15 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-a182-7478-a206-bd302dbd0be5,01a120c6-6e2d-7aea-acb1-80ec20078803;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5df0-7afd-88af-4bc7118775dc,01a1208c-c1bf-7091-840a-43fb2478fef2,01a1208d-6081-7358-8ad7-c73ab9b7f04d,01a1208e-d6d4-718c-9e50-7cf7cf768126,01a12092-876b-7b35-bb9a-14a92cb9a4c7;count=15 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/000752
- Registration status
- Active
- ATC code
- L01BB07
Sources
- product · EMA · EMEA/H/C/000752 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000752 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000752 · Verified 2026-10-09